3F
BSX icon

360 Financial’s Boston Scientific BSX Stock Holding History

360 Financial’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$240K Hold
3,824
– – 0.07% 69
2025
Q4 		$365K Hold
3,824
– – 0.11% 57
2025
Q3 		$373K Sell
3,824
-281
-7% -$29.1K 0.12% 58
2025
Q2 		$441K Buy
+4,105
New +$415K 0.14% 54

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

360 Financial's BSX Position: Q1 2026 in Review

360 Financial held its Boston Scientific (BSX) position steady in Q1 2026 at 3,824 shares worth $240K. The position accounts for 0.07% of the portfolio, ranked #69.

360 Financial first reported a position in BSX in Q2 2025 and has held it in 4 quarters since. The position peaked at $441K in Q2 2025. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • 360 Financial held 3,824 shares of Boston Scientific worth $240K as of Q1 2026.
  • 360 Financial left its Boston Scientific share count unchanged in Q1 2026.
  • Boston Scientific made up 0.07% of 360 Financial's portfolio in Q1 2026, its #69 holding.
  • 360 Financial first reported a position in Boston Scientific in Q2 2025 and has held it in 4 quarters since.
  • 360 Financial's Boston Scientific position peaked at $441K in Q2 2025.
  • 1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on 360 Financial's 13F filing for Q1 2026, filed 7 May 2026.